Overall rank by patents
#1,083
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Roche Molecular Systems, Inc.
USPTO PatentsView assignee record — 395 granted patents across 67 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
395
Total patents granted
67
CPC technology areas
11.7
Avg claims per patent
-12%
5-year filing velocity
Portfolio overview
Roche Molecular Systems, Inc. has been granted 395 US utility patents between 2015 and 2025, placing Roche Molecular Systems, Inc. at rank #1,083 across all assignees tracked by PlainPatent. This portfolio spans 67 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.7 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Roche Molecular Systems, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 57.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 185 grants, compared with 210 in the 2015–2019 window — a -12% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Roche Molecular Systems, Inc.'s 11.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 67 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Roche Molecular Systems, Inc. against peers pursuing similar technology classes.
How does Roche compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Roche Molecular S… ◀ 395
Roche Molecular Systems, Inc.
395 patents
What this shows Roche holds 395 patents — placing it at rank #1,083 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 32 | 8.1% |
| 2016 | 54 | 13.7% |
| 2017 | 34 | 8.6% |
| 2018 | 55 | 13.9% |
| 2019 | 35 | 8.9% |
| 2020 | 50 | 12.7% |
| 2021 | 32 | 8.1% |
| 2022 | 26 | 6.6% |
| 2023 | 30 | 7.6% |
| 2024 | 33 | 8.4% |
| 2025 | 14 | 3.5% |
Which technologies does Roche Molecular Systems, Inc. patent most?
Top 15 of 67 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does Roche Molecular Systems, Inc. hold?
Roche Molecular Systems, Inc. holds 395 US granted patents filed between 2015 and 2025, spanning 67 technology areas.
What is Roche Molecular Systems, Inc.'s Innovation Score?
Roche Molecular Systems, Inc. has an Innovation Score of 57.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Roche Molecular Systems, Inc. focus on?
Roche Molecular Systems, Inc.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 220 patents. The company has filed patents in 67 CPC subclasses total.
Is Roche Molecular Systems, Inc.'s patent filing rate increasing or decreasing?
Roche Molecular Systems, Inc.'s recent filing velocity is -12% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Roche Molecular Systems, Inc.'s patents?
Roche Molecular Systems, Inc.'s patents average 11.7 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Roche Molecular Systems, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
C12Q technology
Roche Molecular Systems, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Roche Molecular Systems, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
